Li Benhao, Liu Hengke, He Yaling, Zhao Mengyao, Ge Chen, Younis Muhammad Rizwan, Huang Peng, Chen Xiaoyuan, Lin Jing
Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, 518060, China.
Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, 119074, Singapore.
Angew Chem Int Ed Engl. 2022 Apr 11;61(16):e202200025. doi: 10.1002/anie.202200025. Epub 2022 Feb 21.
We present a second near-infrared (NIR-II) self-checking molecule, LET-1052, for acidic tumor microenvironment (TME) turn-on photothermal therapy (PTT), followed by viscosity based therapeutic efficacy evaluation by itself in two independent channels, denoted as "self-checking" strategy. In acidic TME, LET-1052 was protonated and turned on NIR-II absorption for PTT under 1064 nm laser irradiation. Subsequently, PTT-induced cellular death increases intracellular viscosity, which inhibited the intramolecular rotation of LET-1052, resulting in the enhancement of NIR-I fluorescence for real-time evaluation of PTT efficacy. After PTT of tumor-bearing mice for different periods of NIR-II laser irradiation, NIR-I fluorescence in the tumor region showed positive correlation with tumor growth inhibition rate, demonstrating reliable and prompt prediction of PTT efficacy. The strategy may be expanded for instant evaluation of other therapeutic modalities for personalized medicine.
我们提出了第二种用于酸性肿瘤微环境(TME)开启光热疗法(PTT)的近红外二区(NIR-II)自检测分子LET-1052,随后通过其自身在两个独立通道中基于粘度的治疗效果评估,即“自检测”策略。在酸性TME中,LET-1052被质子化,并在1064 nm激光照射下开启用于PTT的近红外二区吸收。随后,PTT诱导的细胞死亡增加了细胞内粘度,这抑制了LET-1052的分子内旋转,导致近红外一区荧光增强,用于实时评估PTT疗效。对荷瘤小鼠进行不同时长的近红外二区激光照射PTT后,肿瘤区域的近红外一区荧光与肿瘤生长抑制率呈正相关,证明了对PTT疗效的可靠且即时的预测。该策略可扩展用于即时评估其他个性化医学治疗模式。